Explore our resources
Webinar
GSK: From Pilot Projects to Enterprise Adoption
Posit teamed up with GSK's Data Science Innovation and Engineering team to discuss how GSK, a leading pharmaceutical company, transformed its biostatistics toolkit by embracing R.
Webinar
How Data Science is Revolutionizing Insurance
Fireside chat with leaders from Milliman, The Hartford, and Plymouth Rock Assurance.
Webinar
Introducing Connect Cloud for Organizations: Easily share your data work internally and externally
Learn how new features in Connect Cloud make it easier for teams to deploy, share, and collaborate securely.
Webinar
Johnson & Johnson’s Open Source Journey in R
Johnson & Johnson is charting a new path for clinical trial submissions; one built on transparency, efficiency, and collaboration through open-source tooling and R.
Webinar
Level Up Your Data Game: Databricks + Posit Integration for R Users
See how modern sports analytics teams are transforming their workflows and how you can too.
Webinar
Novo Nordisk: Journey to an R-based FDA submission
The leading pharmaceutical company behind life-changing medicines such as Ozempic, joined Posit to share their celebratory milestone in drug development - an NDA submission using open-source tooling.
Webinar
Posit and the modern data stack: Using Posit tools alongside Snowflake & Databricks
James Blair discusses the integration of Posit tools with partners like Snowflake and Databricks, emphasizing the role of AI in enhancing data scientists' efficiency. He demonstrates the use of Positron Assistant and Databot for data exploration without transferring data locally, ensuring data security.
Webinar
Publishing R & Python Work: Evaluating Connect and Connect Cloud
Join Posit’s Alex Chisholm and Matt Leary to learn how Posit Connect and Connect Cloud can help you rapidly and securely publish data science work.
Webinar
Removing the Data Obstacles in Data Science
Stop fighting your data and start using it. Watch Posit and Databricks discuss best practices for overcoming data governance hurdles and streamlining access to company assets.